- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 740105, 15 pages
The Renal Effects of Vanadate Exposure: Potential Biomarkers and Oxidative Stress as a Mechanism of Functional Renal Disorders—Preliminary Studies
1Laboratory of Physiology and Animal Biochemistry, Department of Zoology and Invertebrate Ecology, Institute of Environmental Protection, The John Paul II Catholic University of Lublin, 102 Kraśnicka Avenue, 20-718 Lublin, Poland
2Laboratory of Oxidative Stress, Center for Interdisciplinary Research, The John Paul II Catholic University of Lublin, 102 Kraśnicka Avenue, 20-718 Lublin, Poland
3Laboratory of Separation and Spectroscopic Method Applications, Center for Interdisciplinary Research, The John Paul II Catholic University of Lublin, 102 Kraśnicka Avenue, 20-718 Lublin, Poland
Received 30 April 2013; Revised 22 October 2013; Accepted 28 October 2013; Published 28 January 2014
Academic Editor: Maha Zaki Rizk
Copyright © 2014 Agnieszka Ścibior et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. Z. Byczkowski and A. P. Kulkarni, “Oxidative stress and pro-oxidant biological effects of vanadium,” in Vanadium in the Environment Part II: Health Effects, J. O. Nriagu, Ed., pp. 235–264, John Wiley and Sons, New York, NY, USA, 1998.
- A. Ścibior, H. Zaporowska, and I. Niedźwiecka, “Lipid peroxidation in the liver of rats treated with V and/or Mg in drinking water,” Journal of Applied Toxicology, vol. 29, no. 7, pp. 619–628, 2009.
- A. Ścibior, H. Zaporowska, and I. Niedźwiecka, “Lipid peroxidation in the kidney of rats treated with V and/or Mg in drinking water,” Journal of Applied Toxicology, vol. 30, no. 5, pp. 487–496, 2010.
- A. Ścibior, D. Gołębiowska, and I. Niedźwiecka, “Magnesium can protect against vanadium-induced lipid peroxidation in the hepatic tissue,” Oxidaive Medicine and Cellular Longevity, vol. 2013, Article ID 802734, 11 pages, 2013.
- J. Donaldson and F. LaBella, “Prooxidant properties of vanadate in vitro on catecholamines and on lipid peroxidation by mouse and rat tissues,” Journal of Toxicology and Environmental Health, vol. 12, no. 1, pp. 119–126, 1983.
- M. H. Oster, J. M. Llobet, J. L. Domingo, J. B. German, and C. L. Keen, “Vanadium treatment of diabetic Sprague-Dawley rats results in tissue vanadium accumulation and pro-oxidant effects,” Toxicology, vol. 83, no. 1–3, pp. 115–130, 1993.
- S. S. Soares, H. Martins, R. O. Duarte et al., “Vanadium distribution, lipid peroxidation and oxidative stress markers upon decavanadate in vivo administration,” Journal of Inorganic Biochemistry, vol. 101, no. 1, pp. 80–88, 2007.
- J. Donaldson, R. Hemming, and F. LaBella, “Vanadium exposure enhances lipid peroxidation in the kidney of rats and mice,” Canadian Journal of Physiology and Pharmacology, vol. 63, no. 3, pp. 196–199, 1985.
- M. Carmignani, A. R. Volpe, E. Sabbioni, M. Felaco, and P. Boscolo, “Vanadium and the cardiovascular system: regulatory effects and toxicity,” in Vanadium in the Environment Part II: Health Effects, J. O. Nriagu, Ed., vol. 31, pp. 181–219, John Wiley and Sons, New York, NY, USA, 1998.
- K. De Cremer, M. Van Hulle, C. Chéry et al., “Fractionation of vanadium complexes in serum, packed cells and tissues of Wistar rats by means of gel filtration and anion-exchange chromatography,” Journal of Biological Inorganic Chemistry, vol. 7, no. 7-8, pp. 884–890, 2002.
- V. Sitprija, K. Tungsanga, P. Tosukhowong et al., “Metabolic problems in northeastern Thailand: possible role of vanadium,” Mineral and Electrolyte Metabolism, vol. 19, no. 1, pp. 51–56, 1993.
- E. Dafnis and S. Sabatini, “Biochemistry and pathophysiology of vanadium,” Nephron, vol. 67, no. 2, pp. 133–143, 1994.
- P. Tosukhowong, K. Tungsanga, S. Eiam-Ong, and V. Sitprija, “Environmental distal renal tubular acidosis in Thailand: an enigma,” American Journal of Kidney Diseases, vol. 33, no. 6, pp. 1180–1186, 1999.
- A. S. Tracey, G. R. Willsky, and E. S. Takeuchi, Vanadium—Chemistry, Biochemistry, Pharmacology and Practical Applications, Taylor and Francis, Boca Raton, Fla, USA, 2007.
- S. M. Talbott and K. Hughes, The Health Professional’s Guide to Dietary Supplements, Lippincott Williams and Wilkins, 2007.
- V. Sitprija and S. Eiam-Ong, “Vanadium and metabolic problems,” in Vanadium in the Environment Part II: Health Effects, J. O. Nriagu, Ed., pp. 91–120, John Wiley and Sons, New York, NY, USA, 1998.
- Y. Teng, S. Ni, C. Zhang, J. Wang, X. Lin, and Y. Huang, “Environmental geochemistry and ecological risk of vanadium pollution in Panzhihua mining and smelting area, Sichuan, China,” Chinese Journal of Geochemistry, vol. 25, no. 4, pp. 379–385, 2006.
- Expert group on vitamins and minerals, Review of vanadium. EVM/00/04.REVISEDAUG, 2002.
- K. H. Thompson, M. Battell, and J. H. McNeill, “Toxicology of vanadium in mammals,” in Vanadium in the Environment Part II: Health Effects, J. O. Nriagu, Ed., pp. 21–38, John Wiley and Sons, New York, NY, USA, 1998.
- R. G. Fassett, S. K. Venuthurupalli, G. C. Gobe, J. S. Coombes, M. A. Cooper, and W. E. Hoy, “Biomarkers in chronic kidney disease: a review,” Kidney International, vol. 80, no. 8, pp. 806–821, 2011.
- G. D'Amico and C. Bazzi, “Urinary protein and enzyme excretion as markers of tubular damage,” Current Opinion in Nephrology and Hypertension, vol. 12, no. 6, pp. 639–643, 2003.
- V. S. Vaidya, V. Ramirez, T. Ichimura, N. A. Bobadilla, and J. V. Bonventre, “Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury,” American Journal of Physiology—Renal Physiology, vol. 290, no. 2, pp. F517–F529, 2006.
- A. Ścibior, A. Adamczyk, D. Gołebiowska, and I. Niedźwiecka, “Effect of 12-week vanadate and magnesium co-administration on chosen haematological parameters as well as on some indices of iron and copper metabolism and biomarkers of oxidative stress in rats,” Environmental Toxicology and Pharmacology, vol. 34, no. 2, pp. 235–252, 2012.
- J. L. Domingo, M. Gomez, D. J. Sanchez, J. M. Llobet, and C. L. Keen, “Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation,” Molecular and Cellular Biochemistry, vol. 153, no. 1-2, pp. 233–240, 1995.
- J. Azay, J. Brès, M. Krosniak et al., “Vanadium pharmacokinetics and oral bioavailability upon single-dose administration of vanadyl sulfate to rats,” Fundamental and Clinical Pharmacology, vol. 15, no. 5, pp. 313–324, 2001.
- World Health Organization, Vanadium Pentoxide and Other Inorganic Vanadium Compounds, WHO, Geneva, Switzerland, 2001.
- International Agency for Research on Cancer Monographs on the evaluation of carcinogenic risks to humans, Cobalt in Hard Metals and Cobalt Sulfate, Gallium Arsenide, Indium Phosphide and Vanadium Pentoxide, vol. 86, Lyon, France, 2006.
- A. Ścibior and H. Zaporowska, “Effects of vanadium(V) and/or chromium(III) on L-ascorbic acid and glutathione as well as iron, zinc, and copper levels in rat liver and kidney,” Journal of Toxicology and Environmental Health A, vol. 70, no. 8, pp. 696–704, 2007.
- D. A. Barrio and S. B. Etcheverry, “Vanadium and bone development: putative signaling pathways,” Canadian Journal of Physiology and Pharmacology, vol. 84, no. 7, pp. 677–686, 2006.
- A. Ścibior, H. Zaporowska, A. Wolińska, and J. Ostrowski, “Antioxidant enzyme activity and lipid peroxidation in the blood of rats co-treated with vanadium (V+5) and chromium (Cr+3),” Cell Biology and Toxicology, vol. 26, no. 6, pp. 509–526, 2010.
- A. C. Baxmann, M. S. Ahmed, N. C. Marques et al., “Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 2, pp. 348–354, 2008.
- P. D. Sarkar, G. Rajeshwari, and T. M. Shivaprakash, “Cystatin C—A novel marker of glomerular filtration: a review,” Indian Journal of Clinical Biochemistry, vol. 20, no. 1, pp. 139–144, 2005.
- G. H. Tesch, “Review: serum and urine biomarkers of kidney disease: a pathophysiological perspective,” Nephrology, vol. 15, no. 6, pp. 609–616, 2010.
- M. Warwas and A. Piwowar, “Moczowa cystatyna C jako biomarker uszkodzenia kanalików nerkowych,” Postępy Higieny i Medycyny Doświadczalnej, vol. 65, pp. 562–568, 2011.
- J. Westhuyzen, “Cystatin C: a promising marker and predictor of impaired renal function,” Annals of Clinical and Laboratory Science, vol. 36, no. 4, pp. 387–394, 2006.
- A. De La Torre, S. Granero, E. Mayayo, J. Corbella, and J. L. Domingo, “Effect of age on vanadium nephrotoxicity in rats,” Toxicology Letters, vol. 105, no. 1, pp. 75–82, 1999.
- A. M. Cortizo, V. C. Salice, and S. B. Etcheverry, “Vanadium compounds: their action on alkaline phosphatase activity,” Biological Trace Element Research, vol. 41, no. 3, pp. 331–339, 1994.
- A. M. Evangelou, “Vanadium in cancer treatment,” Critical Reviews in Oncology/Hematology, vol. 42, no. 3, pp. 249–265, 2002.
- A. Ścibior and H. Zaporowska, “Effects of combined vanadate and magnesium treatment on erythrocyte antioxidant defence system in rats,” Environmental Toxicology and Pharmacology, vol. 30, no. 2, pp. 153–161, 2010.
- X.-G. Yang, X.-D. Yang, L. Yuan, K. Wang, and D. C. Crans, “The permeability and cytotoxicity of insulin-mimetic vanadium compounds,” Pharmaceutical Research, vol. 21, no. 6, pp. 1026–1033, 2004.
- J. Liu, H. Cui, X. Liu et al., “Dietary high vanadium causes oxidative damage-induced renal and hepatic toxicity in broilers,” Biological Trace Element Research, vol. 145, no. 2, pp. 189–200, 2012.